MedTrace Logo

Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer

NCT01117389 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 587

Last updated 2015-08-27

No results posted yet for this study

Summary

This study will focus on the primary objectives:

* To estimate the prevalence of HPV vaccination among a large cohort of childhood cancer survivors and an acquaintance control group.
* To describe the difference in HPV vaccination rate and HPV vaccination intent among preadolescent/adolescent females surviving childhood cancer and an acquaintance control group.

This study will also focus on the secondary objectives:

* To examine sociodemographic, medical, and psychological differences between those who have/have not initiated HPV vaccination and between those who do/do not intend to get vaccinated in the future.
* To assess the general predictive influence of sociodemographic, medical, and psychological variables on HPV vaccination and intent among mothers with preadolescent/adolescent daughters.

Conditions

  • Human Papillomavirus

Sponsors & Collaborators

Principal Investigators

  • James Klosky, Ph.D · St. Jude Children's Research Hospital

Eligibility

Min Age
9 Years
Max Age
26 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01117389 on ClinicalTrials.gov